SLV News Alert Silver Trust Ishares (SLV) 15.06 01/01/2015 1

New Post Public Reply Private Reply Replies (0) Message Board

Jan 1, 2015 at 4:44 PM

Silver Trust Ishares (SLV) 15.06 $SLV

Forecast 2015: The Year Ahead In The Money Metals
Money Metals Exchange - at Seeking Alpha - Wed Dec 31, 4:10PM CST
By Stefan Gleason The "year that was" brought mostly disappointment to precious metals bulls. Silver prices fell for the third straight year, while gold mostly flat-lined around the $1,200 per-ounce level. So, what about the year to...
PALL: 77.49 (-0.51), GLD: 113.58 (-1.62), SLV: 15.06 (-0.52), PPLT: 117.05 (-0.85)

Expect More Volatility in Gold for 2015 as Interest Rates Rise
at The Street - Wed Dec 31, 3:59PM CST
Gold has been trading around the $1200 level for a good portion of 2014 and independent metals trader Eric Zuccarelli sees more volatility and consolidation in gold for 2015.
GDXJ: 23.93 (-0.19), GLD: 113.58 (-1.62), SLV: 15.06 (-0.52), GDX: 18.38 (-0.07)

Gold In 2015 - When The Russian Empire Strikes Back
Markos Kaminis - at Seeking Alpha - Wed Dec 31, 10:45AM CST

GDXJ: 23.93 (-0.19), GLD: 113.58 (-1.62), OIL: 12.54 (+0.04), PHYS: 9.77 (-0.14), DUST: 24.66 (+0.16), SLV: 15.06 (-0.52), NUGT: 11.16 (-0.09), GDX: 18.38 (-0.07), GG: 18.52 (-0.07)

The Outlook For Silver In 2015
Prudent Finances - at Seeking Alpha - Wed Dec 31, 9:50AM CST

DBS: 25.27 (-0.96), AGQ: 38.05 (-2.77), USLV: 18.99 (-2.29), USV: 21.05 (-0.85), SIVR: 15.43 (-0.61), SLV: 15.06 (-0.52), DSLV: 72.98 (+6.80), ZSL: 119.39 (+8.31)

iShares Silver Trust Set to Possibly Pullback After Yesterday's Rally of 3.11%
Comtex SmarTrend(R) - Tue Dec 30, 3:53PM CST
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $15.32 to a high of $15.77. Yesterday, the shares gained 3.1%, which took the trading range above the 3-day high of $15.51 on volume of 11.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SLV: 15.06 (-0.52)

Watch for iShares Silver Trust to Potentially Pullback After Gaining 3.11% Yesterday
Comtex SmarTrend(R) - Tue Dec 30, 3:53PM CST
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $15.32 to a high of $15.77. Yesterday, the shares gained 3.1%, which took the trading range above the 3-day high of $15.51 on volume of 11.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SLV: 15.06 (-0.52)

Why I'm A Bearish Gold Bug
Edward Vranic, CFA - at Seeking Alpha - Tue Dec 30, 2:55PM CST

GLD: 113.58 (-1.62), SLV: 15.06 (-0.52), GDX: 18.38 (-0.07)

Will Higher Physical Demand For Silver Drive Up SLV?
Lior Cohen - at Seeking Alpha - Mon Dec 29, 5:13PM CST

GLD: 113.58 (-1.62), SLV: 15.06 (-0.52)

A Tale Of 2 Metals: Gold And Silver Divergence
Andrew Hecht - at Seeking Alpha - Mon Dec 29, 5:15AM CST

SGOL: 115.85 (-1.58), USLV: 18.99 (-2.29), OUNZ: 11.81 (-0.16), GLD: 113.58 (-1.62), SIVR: 15.43 (-0.61), IAU: 11.44 (-0.16), SLV: 15.06 (-0.52), AGOL: 118.09 (+2.35)

2014's Trash Could Be 2015's Treasure
Eric Parnell, CFA - at Seeking Alpha - Sat Dec 27, 2:41AM CST

PALL: 77.49 (-0.51), DBB: 15.90 (-0.13), VXX: 31.51 (+2.31), FXY: 81.21 (-0.20), JJU: 17.96 (-0.12), XLU: 47.22 (-0.87), TLT: 125.92 (+0.24), PPLT: 117.05 (-0.85), EWJ: 11.24 (-0.06), JJN: 19.98 (+0.20), SPY: 205.54 (-2.06), IEV: 42.53 (-0.31), GLD: 113.58 (-1.62), OIL: 12.54 (+0.04), FXB: 153.06 (+0.24), SLV: 15.06 (-0.52), ACWX: 43.02 (-0.21), FXE: 119.14 (-0.53), VNQ: 81.00 (-1.39), JJC: 33.96 (-0.39), EPP: 43.95 (-0.34), XLE: 79.16 (-0.60)

After Yesterday's Rally of 1.72% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Dec 26, 3:58PM CST
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $15.35 to a high of $15.51. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $15.31 on volume of 4.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SLV: 15.06 (-0.52)

Gold and silver stocks rally on China hopes
Seeking Alpha - at Seeking Alpha - Fri Dec 26, 2:34PM CST

GLDI: 11.97 (-0.16), OUNZ: 11.81 (-0.16), HL: 2.79 (+0.01), UGLD: 11.22 (-0.50), GFI: 4.53 (+0.02), SIVR: 15.43 (-0.61), DSLV: 72.98 (+6.80), GLDE: 12.56 (unch), GYEN: 13.12 (-0.14), SGOL: 115.85 (-1.58), GEUR: 12.41 (-0.15), AGQ: 38.05 (-2.77), KGC: 2.82 (+0.02), SLW: 20.33 (+0.09), AGI: 7.13 (+0.05), SLV: 15.06 (-0.52), ZSL: 119.39 (+8.31), CDE: 5.11 (-0.01), UGL: 38.41 (-1.12), BARS: 47.25 (-1.58), TBAR: 25.03 (+0.02), ABX: 10.75 (-0.11), USV: 21.05 (-0.85), DZZ: 7.56 (+0.20), SSRI: 5.01 (+0.07), DGL: 39.14 (-0.58), EXK: 2.16 (-0.02), DGP: 23.50 (-0.66), DGLD: 77.17 (+2.66), DBS: 25.27 (-0.96), UBG: 30.67 (-1.05), SLVO: 11.23 (-0.35), AG: 5.02 (-0.03), USLV: 18.99 (-2.29), DGZ: 15.67 (+0.21), GLD: 113.58 (-1.62), PAAS: 9.20 (-0.05), IAU: 11.44 (-0.16), GGBP: 11.50 (unch), BAR: 26.98 (-1.34), AGOL: 118.09 (+2.35), TAHO: 13.87 (-0.03), AUY: 4.02 (-0.05), GLL: 100.22 (+2.28), GG: 18.52 (-0.07), SVM: 1.30 (-0.04)

Best Of The Best: The Most Popular Thoughts From 2014
The Gold Report - at Seeking Alpha - Thu Dec 25, 7:20AM CST
As natural resources bounced all over the charts in 2014, readers turned to the experts interviewed by The Gold Report for insights on what was driving these ups and downs and how they could protect themselves or, better yet, benefit from the...
SGOL: 115.85 (-1.58), OUNZ: 11.81 (-0.16), GLD: 113.58 (-1.62), SIVR: 15.43 (-0.61), IAU: 11.44 (-0.16), SLV: 15.06 (-0.52), AGOL: 118.09 (+2.35)

Dear Dr. Yellen, Forget About Inflation, Deflation Is The Real Concern
Mycroft - at Seeking Alpha - Thu Dec 25, 7:14AM CST

NKY: 17.07 (-0.08), SPY: 205.54 (-2.06), GLD: 113.58 (-1.62), DIA: 177.88 (-1.58), SLV: 15.06 (-0.52), INTC: 36.29 (-0.47), BA: 129.98 (-1.85), AAPL: 110.38 (-2.14), CSCO: 27.82 (-0.54)

Gold Outlook For 2015 - Buy And Hold Here
Markos Kaminis - at Seeking Alpha - Thu Dec 25, 1:35AM CST

GLD: 113.58 (-1.62), NEM: 18.90 (-0.36), PHYS: 9.77 (-0.14), DUST: 24.66 (+0.16), SLV: 15.06 (-0.52), NUGT: 11.16 (-0.09), GDX: 18.38 (-0.07), GG: 18.52 (-0.07)

Interesting SLV Put And Call Options For February 2015
at The Street - Wed Dec 24, 11:12AM CST
Investors in iShares Silver Trust saw new options become available today, for the February 2015 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SLV options chain for the new February 2015 contracts and...
SLV: 15.06 (-0.52)

History Shows That Silver Prices Should Start To Grow
Peter Arendas - at Seeking Alpha - Tue Dec 23, 9:40AM CST

GLD: 113.58 (-1.62), SIVR: 15.43 (-0.61), SLV: 15.06 (-0.52)

iShares Silver Trust Set to Possibly Rebound After Yesterday's Selloff of 2.60%
Comtex SmarTrend(R) - Mon Dec 22, 4:42PM CST
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $14.87 to a high of $15.31. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $14.96 on volume of 10.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SLV: 15.06 (-0.52)

Watch for iShares Silver Trust to Potentially Rebound After Falling 2.60% Yesterday
Comtex SmarTrend(R) - Mon Dec 22, 4:41PM CST
iShares Silver Trust (AMEX:SLV) traded in a range yesterday that spanned from a low of $14.87 to a high of $15.31. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $14.96 on volume of 10.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SLV: 15.06 (-0.52)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

TORRAS Cases Balance Protection with Slim Design for 2026

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Master Sommeliers and Italian Producers Clash on Wine Lists

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...